EFFECT OF TERBINAFINE, ITRACONAZOLE AND GRISEOFULVIN IN TINEA INFECTION MODIFIED BY STEROID USE
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2023/06/053409
- Lead Sponsor
- CMS and GTB Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients with clinically suspected lesions of tinea with positive microscopic examination with history of topical or systemic steroid use prior to study.
2.Patients of either sex, aged 18 -65 years
3.Willing to give written informed consent to participate in the study
1.Pregnant and lactating women
2.Patients having clinical diagnosis of tinea infections other than tinea corporis, tinea cruris and tinea faciei.
3.History of use of antifungal drugs in past 4 weeks
4.History of known allergy to study drugs.
5.Patients with severe comorbidities: mental illness, liver and renal disease, cardiac failure and other co-existing dermatological diseases
6.Immunocompromised patients and patients on Immunosuppressive drugs during study duration or in past 2 weeks.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method